bismuth Bi213 monoclonal antibody M195
Term · Oncology and biomedicine · MLC-T-ONC-012029
A radioimmunoconjugate consisting of murine monoclonal antibody (M195) and bismuth 213 (Bi213). Monoclonal antibody M195 binds to CD33, a surface antigen expressed by myelogenous leukemia cells. Bismuth 213 is an isotope that emits short-ranged high-energy alpha particles. This radioimmunoconjugate selectively delivers alpha particle-mediated cytotoxicity to leukemic cells, thereby limiting the exposure of normal tissues to ionizing radiation.
| Identifier | MLC-T-ONC-012029 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | Bi213 MOAB M195 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012029",
"term": "bismuth Bi213 monoclonal antibody M195",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate consisting of murine monoclonal antibody (M195) and bismuth 213 (Bi213). Monoclonal antibody M195 binds to CD33, a surface antigen expressed by myelogenous leukemia cells. Bismuth 213 is an isotope that emits short-ranged high-energy alpha particles. This radioimmunoconjugate selectively delivers alpha particle-mediated cytotoxicity to leukemic cells, thereby limiting the exposure of normal tissues to ionizing radiation.",
"abbreviation": "Bi213 MOAB M195",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bismuth-bi213-monoclonal-antibody-m195/"
}
Record 3,605 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.